
Jeffrey Haskell Fair MD
Hepatobiliary Surgery, Pancreas, Transplantation, Trauma Surgery & Surgical Critical Care
Professor Surgery, University of Texas Medical Branch, Chief, Division of Transplant and Hepatobiliary Surgery, Director UTMB Transplant Center
Join to view full profile
508 Jefferson StWhiteville, NC 28472
Phone+1 910-640-2480
Fax+1 910-640-2487
Dr. Fair is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins University School of MedicineFellowship, Abdominal Transplant Surgery, 1989 - 1991
ECU Health Medical Center/East Carolina UniversityResidency, Surgery, 1983 - 1989
Brody School of Medicine at East Carolina UniversityClass of 1983
Certifications & Licensure
CA State Medical License 2008 - Present
NC State Medical License 1985 - 2026
TX State Medical License 2017 - 2025
FL State Medical License 2012 - 2020
MD State Medical License 1989 - 1994
American Board of Surgery Surgery
American Board of Surgery Surgical Critical Care
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 1 citationsAmniotic Fluid Reduces Liver Fibrosis By Attenuating Hepatic Stellate Cell Activation.Charles M Bowen, Frederick Ditmars, Naiyou Liu, Jose Marri Abril, David Ajasin
Biorxiv. 2025-07-30 - Amniotic fluid reduces liver fibrosis by attenuating hepatic stellate cell activation.Charles M Bowen, Frederick Ditmars, Naiyou Liu, Jose Marri Abril, David Ajasin
Stem Cells Translational Medicine. 2025-06-25 - An uncommon complication after living donor nephrectomy.Vincenzo Villani, Jeffrey H Fair, Rupak D Kulkarni
American Journal of Transplantation. 2025-02-01
Press Mentions
- Hepatocellular Carcinoma Recurrence and Death Following Living and Deceased Donor Liver TransplantationJuly 23rd, 2020
Grant Support
- Correction Of Hemophilia By Embryonic Stem Cell TransplantationNational Heart, Lung, And Blood Institute2008
- Correction Of Hemophilia By Embryonic Stem Cell TransplantationNational Heart, Lung, And Blood Institute2007
- Right Lobe Living Donor Liver Transplantation In AdultsNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2007
- Correction Of Hemophilia In Mice By Embryonic Stem Cell*National Heart, Lung, And Blood Institute2006
- Therapy Of Hemophilia By Embryonic Stem Cell TransplantsNational Heart, Lung, And Blood Institute2005
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: